In mammalian cells homologous recombination is stimulated, when the replication fork stalls at DNA breaks or unrepaired lesions. The tumor suppressor p53 downregulates homologous recombination independently of its transcriptional transactivation function and has been linked to enzymes of DNA recombination and replication. To study recombination with respect to replication, we utilized a SV40 virus based assay, to follow the synchronous events after primate cell infection. g-ray treatment at different times after viral entry unveiled an increase of interchromosomal exchange frequencies, when the damage was introduced during DNA synthesis. Elevated recombination frequencies were fully suppressed by p53. With respect to the downregulation of spontaneous recombination, we noticed a requirement for active p53 molecules, when replication started. After a transient treatment with replication inhibitors, we observed inhibition of the drug induced recombination by p53, particularly for the elongation inhibitor aphidicolin. Consequently, we propose that p53 is a surveillance factor of homologous recombination at replication forks, when they stall as a consequence of endogenous or of exogenously introduced damage.
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Keywords: aphidicolin; DNA synthesis; gene conversion; SV40 chromosomes; tumor suppressor Homologous recombination is a major pathway of double-strand break (DSBs) repair in mammalian cells (Liang et al., 1998) . In mitotically growing cells homologous recombination is critically important during replication, when DSBs are generated during lagging strand synthesis or when unrepaired lesions cause replication fork stalling (Cox et al., 2000; Thompson and Schild, 2001 ). Faithful recombination is necessary to avoid chromosomal aberrations and is taken care of by surveillance factors, which have been linked to replication enzymes.
Soon after having established p53 as the most frequently altered gene in human tumors, p53 was understood as a major component of the DNA damage response pathway (Hollstein et al., 1994; Levine, 1997) . Loss of p53 function was shown to be associated with genetic instabilities, which become manifested as aneuploidies, allelic losses, increases in sister chromatid exchanges and in gene amplification rates (Livingstone et al., 1992; Ishizaki et al., 1994) . Wild-type p53 (wtp53) stabilizes the genome by G1 arrest and pro-apoptotic functions, thereby giving time to repair and eliminate cells with irrepairable damage, respectively (Levine, 1997) . During the last years it was also established that p53 downregulates homologous recombination independently of its transcriptional transactivation and growth regulatory functions (Saintigny et al., 1999; Dudenho¨ffer et al., 1999; Willers et al., 2000) . This activity is directed towards gene conversion events, involving short stretches of homologies in particular (Bertrand et al., 1997; Saintigny et al., 1999; Akyu¨z et al., 2002) . Therefore, a genome stabilizing role of p53 in counteracting detrimental rearrangements between divergent sequences was proposed.
Direct links between p53 and the mammalian RecA homologue Rad51 were indicated by the results from protein -protein and DNA -protein interaction studies (Stu¨rzbecher et al., 1996; Su¨sse et al., 2000) . Rad51 was shown to become recruited to replication centres after treatment with either hydroxyurea or UV in S phase (Scully et al., 1997) . Finally, Saintigny et al. (2001) observed Rad51 foci formation and RAD51-dependent stimulation of gene conversion in response to replication inhibition. This indicated a participation of Rad51 in homologous recombination at stalled replication forks. SV40 has proven to be an extremely useful tool for studying DNA replication, since the large tumor antigen (T-Ag) is the only SV40 gene product required, to allow bidirectional replication by the cellular replication enzymes (Brush et al., 1995) . To analyse possible links between p53 and replication-associated recombination, we made use of our SV40 based recombination test system and isogenic monkey cells differing in the p53 status (Wiesmu¨ller et al., 1996; Dudenho¨ffer et al., 1998) .
Effect of p53 on recombination after g-ray treatment of replicating SV40 chromosomes Ionizing radiation creates many types of DNA damage, including strand breaks (Haber, 1999) . Interestingly, we noticed a stimulation of DNA exchange between SV40 chromosomes, when we g-irradiated SV40 infected cells, whereas no significant enhancement was observed, when we irradiated virus during or before infection (data not shown). To identify the events within the infected cell, which caused an increased sensitivity towards irradiation, we investigated interchromosomal exchange as a function of the time of irradiation (Figure 1a) . Two temperature sensitive SV40 variants, which were differently mutated within the region encoding the packaging protein VP1, served to indicate homologous exchange by wild-type virus reconstitution after coinfection of target cells at the nonpermissive temperature of 398C (Wiesmu¨ller et al., 1996; Dudenho¨ffer et al., 1998) . Recombination events per locus and genome were calculated with respect to wild-type virus amplification. Assays were performed in an isogenic cellular system from rhesus monkey, namely in LLC-MK 2 (neo) cells, which are devoid of functional p53, and LLC-MK 2 (p53her) cells, which express the well-characterized and functionally inducible version of wtp53, p53her (Dudenho¨ffer et al., 1998) . After treating LLC-MK 2 (neo) cells with a single dose of 1.5 Gy, no significant rate changes were detected, until 8 h after the infection (h.p.i.). However, irradiation at 10 h.p.i. and 12 h.p.i. caused a gradual increase of up to fourfold elevated frequencies. This stimulatory effect by irradiation dropped, when irradiation was performed at 15 h.p.i. or 24 h.p.i. To understand whether wtp53 is active in regulating homologous recombination after gray induced stimulation, we correspondingly measured recombination in LLC-MK 2 (p53her) cells. Indeed, p53her protein counteracted homologous recombination, by keeping the frequency below 10 73 even after radiation treatment at 12 h.p.i. In parallel, we monitored de novo DNA synthesis under recombination assay conditions by measuring [ 3 H]thymidine incorporation into viral genomes ( Figure 1b ). LLC-MK 2 (neo) and LLC-MK 2 (p53her) cells showed similar DNA synthesis kinetics with a rise between 8 h.p.i. and 15 h.p.i. At later times, i.e. when the release of virus particles started (Von der Weth and Deppert, 1993), SV40 genome amplification declined in both cell lines. From this, it appeared that recombination between SV40 chromosomes was stimulated by g-ray treatment, when newly introduced genomes were replicating. SV40 T-Ag is expressed a few hours before DNA replication starts, binds to viral DNA at replication origins and recruits the cellular replication machinery (Tooze, 1980; Brush et al., 1995) . To study recombination control by ectopically expressed p53her in the absence of p53her-T-Ag interactions (Dudenho¨ffer et al., 1998) , we utilized SV40 virus, which encodes T-Ag with the amino acid exchange D402H and therefore cannot form complexes with p53 (Lin and Simmons, 1991; Wiesmu¨ller et al., 1996) . T-Ag(402H) displays activities in stimulating cellular and viral DNA synthesis like wildtype T-Ag. Analysis of recombination in response to girradiation showed a similar peak during the course of TAg(402H)SV40-tsVP1 coinfections (Figure 2 ). After gray treatment at 10 h.p.i. and 12 h.p.i., we observed 3 -6-fold elevated frequencies. In the presence of p53her DNA exchange values were below 10
73 . This result indicated that p53her counteracted irradiation induced recombination in a fashion independent of any possible recruitment by T-Ag to the sites of repair.
Active p53 molecules are required at the onset of SV40 replication
The appearance of recombinative repair complexes during the cell cycle suggests that homologous recombi- To measure DNA exchange between SV40 chromosomes, we doubly infected target cells with the temperature sensitive strains SV40-tsVP1(196Y) and SV40-tsVP1(290T) at 398C and registered wild-type virus release in comparison to the release after wild-type virus infection (Wiesmu¨ller et al., 1996) . Representative clones of LLC-MK 2 (neo) and LLC-MK 2 (p53her) cells were cultivated in phenol red-free Dulbecco's modified Eagle medium supplemented with 10% charcoal-stripped FCS, until recombination assays were performed in the presence of 2 -5 mM b-estradiol, to functionally activate p53her (Dudenho¨f-fer et al., 1998) . At the indicated hours after infection (h.p.i.) parallel dishes were subjected to g-ray treatment at a dose of 1. (Figure 3 ). When we compared recombination frequencies between LLC-MK 2 (neo) cells and LLC-MK 2 (p53her) cells without the addition of the inducing hormone, we already measured a 5 -10-fold inhibition by p53her. This reflected the basal level of active p53her protein in LLC-MK 2 (p53her) cells due to residual estradiol-like molecules even in the stripped media (Dudenho¨ffer et al., 1998) . After the inclusion of estradiol at 3 h.p.i. or 7 h.p.i., we observed a further, 4 -5-fold enhancement of p53her-dependent inhibition as compared to the inhibition without estradiol addition. Interestingly, this estradiol-dependent inhibitory effect by p53her progressively disappeared, when hormone treatment was started at later times, i.e. between 9 h.p.i. and 16 h.p.i. Thus, maximal downregulation by p53her was executed, when the activating hormone was added before de novo synthesis of SV40 genomes.
p53 counteracts recombination stimulated by treatment with replication inhibitors
The DNA synthesis inhibitors aphidicolin and mimosine have been widely used to study viral and cellular replication processes (Levenson and Hamlin, 1993; Dai et al., 1994; Gilbert et al., 1995; Kalejta and Hamlin, 1997) . Aphidicolin specifically inhibits DNA polymerases a, d, and e during elongation. The effect of mimosine on SV40 replication was reported to be caused by an inhibition of both initiation and elongation, presumably by altering deoxyribonucleotide triphosphate pools. Our results in Table 1 demonstrate that aphidicolin caused a fivefold and mimosine a threefold increase in recombination between SV40 chromosomes, when the drugs were administered at 10 h.p.i. In the presence of p53her 25-fold and eightfold, respectively, lower frequencies were observed. In conclusion, p53 counteracted homologous recombination between SV40 chromosomes particularly, when a replication fork arrest was caused by the specific elongation inhibitor aphidicolin. When we treated LLC-MK 2 (neo) cells with aphidicolin at different times during SV40 genome synthesis, we registered similarly elevated recombination frequencies in the order of 10 72 (Figure 4 ). While p53her was active in reducing recombination frequencies 25-fold, when aphidicolin was administered at 10 h.p.i., inhibition was less effective for later treatments.
Thus, p53 almost completely counteracted aphidicolin-dependent recombination events, when recombination stimulation originated from replication stalling during the first round of SV40 DNA synthesis. This regulatory response could be related to the fact that, despite a low threshold concentration, the antirecom- T-Ag(402H)SV40-tsVP1(196Y) and TAg(402H)SV40-tsVP1(290T) virus strains were performed with LLC-MK 2 (neo) (black rhombs) and LLC-MK 2 (p53her) (grey squares) cells as described for Figure 1 . The data shown correspond to the mean values of quadruplicate measurements from one experiment, which was performed in parallel to double infections with wild-type T-Ag strains Figure 3 Recombination downregulation as a function of p53her activation time. At the indicated times after double infection with the recombination virus strains, 2 -5 mM b-estradiol were included into the estradiol-free culture medium of LLC-MK 2 (neo) (top panel) and LLC-MK 2 (p53her) (bottom panel) cells (Dudenho¨ffer et al., 1998) . Recombination frequencies were quantified from 2 -5 independent experiments from the relative wild-type virus release after double mutant and after wild-type SV40 infection, as for Figure 1 . The basal level of recombination in the absence of estradiol was 4.5610 73 +1.0 for LLC-MK 2 (neo) and 4.6610 74 +0.9 for LLC-MK 2 (p53her)
P53 and replication-associated recombination C Janz and L Wiesmüller binative effect by p53 displays a dose dependency with respect to the p53/DNA ratio (Akyu¨z et al., 2002) . This might explain why the p53-dependent effect was less pronounced after further amplification rounds of SV40 genomes, i.e. in the presence of higher copy numbers.
From their systematic studies on replication-associated recombination on cellular chromosomes, Lopez and colleagues (Saintigny et al., 2001; Saintigny and Lopez, 2002) proposed a preferential effect of p53 on the Rad51-mediated gene conversion step in response to replication elongation inhibition. Our results are compatible with these data. Indeed, our data further strengthen the idea that p53 controls Rad51-dependent DNA exchange processes, since the SV40 based test system primarily detects gene conversion events.
Indications for an antagonistic role of p53 during replication-associated recombination
In this work, we provided evidence for radiation induced stimulation of recombination on replicating SV40 chromosomes. It is important to note that ionizing radiation causes the generation of DSBs, but single-strand breaks are generated far more frequently than DSBs (Fernandez et al., 2001) . Single-strand breaks are converted into DSBs in replicating templates (Larner et al., 1999) . Therefore, as was observed by others for UV, irradiation during replication should lead to increased levels of chromatid breaks (Kaufmann and Wilson, 1994) . Replication-associated recombination serves to bypass unrepaired DNA lesions that inhibit chain elongation, and there are hints that also in SV40 based systems homologous recombination is coupled to DNA replication (Sarasin and Hanawalt, 1978; Kawasaki et al., 1994; Cox et al., 2000) . Therefore, we propose that the p53-dependent downregulation of radiation induced recombination is directed towards replication-associated processes. We did not see significant changes in the overall virus amplification rate, when SV40 infected cells were irradiated at the replication peak. This is compatible with earlier findings, which show that once replication has started, radiation has little effect on the rate of DNA synthesis in eukaryotic chromosomes (Larner et al., 1999) .
Remarkably, independent of exogeneously introduced damage, complete downregulation of homologous recombination by p53 was executed only, when the protein was expressed and active at the onset of replication. Consequently, the antirecombinative effect of p53 might be directed towards replicationassociated processes in general, i.e. during the SV40 life cycle and the mammalian cell cycle. It will be interesting to understand the precise mechanisms, which enable p53 to function as a recombination regulator during DNA replication and inactivate p53 during meiotic recombination (Gersten and Kemp, 1997) .
A possible role of p53 in negatively regulating DNA replication has been discussed (Braithwaite et al., 1987; Von der Weth and Deppert, 1993; Miller et al., 1995) . The results presented here indicate that p53 downregulates SV40 replication weakly (4threefold) as compared to a substantial inhibition of spontaneous homologous recombination (430-fold). p53 has been linked to polymerases on the basis of protein -protein interaction studies (Ku¨hn et al., 1999; Zhou et al., 2001 ) and due to the discovery of a p53-dependent mismatch excision activity in a replication assay (Huang, 1998) . Moreover, exonucleolytic DNA attack by p53 was demonstrated to rise during a Rad51 based strand transfer assay and to decrease with the distance from the junction within heteroduplexes (Su¨sse et al., 2000; Janz et al., 2002) . New models, which indicated that DSB repair proceeds by a variation of the Szostak model, involve newly synthesized DNA in the repaired locus (Haber, 1999) . From this, it can be envisaged that p53 proofreads the heteroduplex either after Rad51-mediated strand invasion or during the subsequent replication step. Therefore, one possible explanation for a p53-dependent retardation of DNA synthesis would be that p53 indirectly causes a prolonged pausing of stalled replication forks due to the inhibitory effect on the recombinative bypass. Figure 4 Effect of replication inhibitors. Recombination assays were performed as described for Table 1 . Starting at 10, 15 or 24 h.p.i., we included aphidicolin at a final concentration of 10 mM for 3 h into the culture medium and prepared DMSO controls in parallel. Results from 2 -3 measurements are indicated for LLC-MK 2 (neo) cells by black bars and for LLC-MK 2 (p53her) cells by white bars P53 and replication-associated recombination C Janz and L Wiesmüller
Remarkably, p53 does not transcriptionally transactivate target genes in cells, which were synchronized in S phase by treatment with a replication elongation inhibitor (Gottifredi et al., 2001) . To the contrary, p53 is active in regulating recombinative repair under these conditions (Saintigny and Lopez, 2002; this work) . In addition, we showed that functional p53 is required exactly at the time, when replication and also replication-associated recombination take place. This strongly indicates a direct rather than a transcriptiondependent action of p53 during recombination. This is in line with earlier reports on the separation of transcriptional, growth regulatory and apoptotic activities of p53 from recombination regulation (Saintigny et al., 1999; Dudenho¨ffer et al., 1999; Willers et al., 2000; Akyu¨z et al., 2002) . Data from in vivo models for transcriptionally inactive p53 indicated the existence of an unidentified activity counteracting cancerogenesis (Komarov et al., 1999; Jimenez et al., 2000) . Errors during recombination are a major source of chromosomal aberrations in mitotically growing cells, so that recombination surveillance by p53 is a good candidate for a tumor suppressor function, which does not rely on transcriptional transactivation.
